Memantine treatment of complex regional pain syndrome

A preliminary report of six cases

Nektarios Sinis, Niels Birbaumer, Sylvia Gustin, Anja Schwarz, Sabine Bredanger, Stephan Thomas Becker, Klaus Unertl, Hans Eberhard Schaller, Max Haerle

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

OBJECTIVES: Recent studies have confirmed the contribution of the central nervous system (CNS) to the pathogenesis of Complex Regional Pain Syndrome (CRPS), because animal models of neuropathic pain syndromes demonstrate an overexpression of N-methyl-D-aspartate-receptors in the CNS. The aim of this work was to study the influence of a central acting drug-the N-methyl-D-aspartate receptor antagonist Memantine-in patients with CRPS of one upper extremity. Here we present the results of 6 patients treated with Memantine for 8 weeks. METHODS: All patients developed CRPS after traumatic injury to one upper extremity. To document changes during the study, levels of pain were measured after clenching the hand using a numeric pain intensity scale ranging from 0 (no pain) to 10 (maximum pain). Motor symptoms were documented for the fingers (fingertips to palm and fingernails to table) and the wrist (flexion/extension). Furthermore, the force was analyzed using a JAMAR-Dynamometer and a Pinchmeter. For assessment of central changes, functional magnetic resonance imaging and magnetoencephalography were used to further document the results of other experiments in 1 patient. Autonomic changes were photographed and pictures were compared before and after treatment with Memantine. RESULTS: Six months after treatment with Memantine, all patients showed a significant decrease in their levels of pain which coincided with an improvement in motor symptoms and autonomic changes. The functional magnetic resonance imaging and magnetoencephalography results provided evidence of cortical reorganization [changes in somatotopic maps in the primary somatosensory cortex (S1)]. These changes returned to a cortical pattern comparable to the unaffected side after treatment with Memantine. DISCUSSION: Based on these first results, the use of Memantine for treatment of CRPS seems promising and supports the hypothesis of a CNS contribution to the pathogenesis and maintenance of neuropathic pain syndromes.

Original languageEnglish
Pages (from-to)237-243
Number of pages7
JournalClinical Journal of Pain
Volume23
Issue number3
DOIs
Publication statusPublished - Mar 2007

Fingerprint

Complex Regional Pain Syndromes
Memantine
Pain
Magnetoencephalography
Central Nervous System
Neuralgia
N-Methyl-D-Aspartate Receptors
Upper Extremity
Therapeutics
Magnetic Resonance Imaging
Somatosensory Cortex
Nails
Wrist
Fingers
Animal Models
Hand
Maintenance
Wounds and Injuries
Pharmaceutical Preparations

Keywords

  • Cortical reorganization
  • CRPS
  • Memantine
  • Neuropathic pain
  • NMDA-receptor

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology

Cite this

Sinis, N., Birbaumer, N., Gustin, S., Schwarz, A., Bredanger, S., Becker, S. T., ... Haerle, M. (2007). Memantine treatment of complex regional pain syndrome: A preliminary report of six cases. Clinical Journal of Pain, 23(3), 237-243. https://doi.org/10.1097/AJP.0b013e31802f67a7

Memantine treatment of complex regional pain syndrome : A preliminary report of six cases. / Sinis, Nektarios; Birbaumer, Niels; Gustin, Sylvia; Schwarz, Anja; Bredanger, Sabine; Becker, Stephan Thomas; Unertl, Klaus; Schaller, Hans Eberhard; Haerle, Max.

In: Clinical Journal of Pain, Vol. 23, No. 3, 03.2007, p. 237-243.

Research output: Contribution to journalArticle

Sinis, N, Birbaumer, N, Gustin, S, Schwarz, A, Bredanger, S, Becker, ST, Unertl, K, Schaller, HE & Haerle, M 2007, 'Memantine treatment of complex regional pain syndrome: A preliminary report of six cases', Clinical Journal of Pain, vol. 23, no. 3, pp. 237-243. https://doi.org/10.1097/AJP.0b013e31802f67a7
Sinis, Nektarios ; Birbaumer, Niels ; Gustin, Sylvia ; Schwarz, Anja ; Bredanger, Sabine ; Becker, Stephan Thomas ; Unertl, Klaus ; Schaller, Hans Eberhard ; Haerle, Max. / Memantine treatment of complex regional pain syndrome : A preliminary report of six cases. In: Clinical Journal of Pain. 2007 ; Vol. 23, No. 3. pp. 237-243.
@article{55bc58e4733c40569ea7be006eb447dc,
title = "Memantine treatment of complex regional pain syndrome: A preliminary report of six cases",
abstract = "OBJECTIVES: Recent studies have confirmed the contribution of the central nervous system (CNS) to the pathogenesis of Complex Regional Pain Syndrome (CRPS), because animal models of neuropathic pain syndromes demonstrate an overexpression of N-methyl-D-aspartate-receptors in the CNS. The aim of this work was to study the influence of a central acting drug-the N-methyl-D-aspartate receptor antagonist Memantine-in patients with CRPS of one upper extremity. Here we present the results of 6 patients treated with Memantine for 8 weeks. METHODS: All patients developed CRPS after traumatic injury to one upper extremity. To document changes during the study, levels of pain were measured after clenching the hand using a numeric pain intensity scale ranging from 0 (no pain) to 10 (maximum pain). Motor symptoms were documented for the fingers (fingertips to palm and fingernails to table) and the wrist (flexion/extension). Furthermore, the force was analyzed using a JAMAR-Dynamometer and a Pinchmeter. For assessment of central changes, functional magnetic resonance imaging and magnetoencephalography were used to further document the results of other experiments in 1 patient. Autonomic changes were photographed and pictures were compared before and after treatment with Memantine. RESULTS: Six months after treatment with Memantine, all patients showed a significant decrease in their levels of pain which coincided with an improvement in motor symptoms and autonomic changes. The functional magnetic resonance imaging and magnetoencephalography results provided evidence of cortical reorganization [changes in somatotopic maps in the primary somatosensory cortex (S1)]. These changes returned to a cortical pattern comparable to the unaffected side after treatment with Memantine. DISCUSSION: Based on these first results, the use of Memantine for treatment of CRPS seems promising and supports the hypothesis of a CNS contribution to the pathogenesis and maintenance of neuropathic pain syndromes.",
keywords = "Cortical reorganization, CRPS, Memantine, Neuropathic pain, NMDA-receptor",
author = "Nektarios Sinis and Niels Birbaumer and Sylvia Gustin and Anja Schwarz and Sabine Bredanger and Becker, {Stephan Thomas} and Klaus Unertl and Schaller, {Hans Eberhard} and Max Haerle",
year = "2007",
month = "3",
doi = "10.1097/AJP.0b013e31802f67a7",
language = "English",
volume = "23",
pages = "237--243",
journal = "Clinical Journal of Pain",
issn = "0749-8047",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Memantine treatment of complex regional pain syndrome

T2 - A preliminary report of six cases

AU - Sinis, Nektarios

AU - Birbaumer, Niels

AU - Gustin, Sylvia

AU - Schwarz, Anja

AU - Bredanger, Sabine

AU - Becker, Stephan Thomas

AU - Unertl, Klaus

AU - Schaller, Hans Eberhard

AU - Haerle, Max

PY - 2007/3

Y1 - 2007/3

N2 - OBJECTIVES: Recent studies have confirmed the contribution of the central nervous system (CNS) to the pathogenesis of Complex Regional Pain Syndrome (CRPS), because animal models of neuropathic pain syndromes demonstrate an overexpression of N-methyl-D-aspartate-receptors in the CNS. The aim of this work was to study the influence of a central acting drug-the N-methyl-D-aspartate receptor antagonist Memantine-in patients with CRPS of one upper extremity. Here we present the results of 6 patients treated with Memantine for 8 weeks. METHODS: All patients developed CRPS after traumatic injury to one upper extremity. To document changes during the study, levels of pain were measured after clenching the hand using a numeric pain intensity scale ranging from 0 (no pain) to 10 (maximum pain). Motor symptoms were documented for the fingers (fingertips to palm and fingernails to table) and the wrist (flexion/extension). Furthermore, the force was analyzed using a JAMAR-Dynamometer and a Pinchmeter. For assessment of central changes, functional magnetic resonance imaging and magnetoencephalography were used to further document the results of other experiments in 1 patient. Autonomic changes were photographed and pictures were compared before and after treatment with Memantine. RESULTS: Six months after treatment with Memantine, all patients showed a significant decrease in their levels of pain which coincided with an improvement in motor symptoms and autonomic changes. The functional magnetic resonance imaging and magnetoencephalography results provided evidence of cortical reorganization [changes in somatotopic maps in the primary somatosensory cortex (S1)]. These changes returned to a cortical pattern comparable to the unaffected side after treatment with Memantine. DISCUSSION: Based on these first results, the use of Memantine for treatment of CRPS seems promising and supports the hypothesis of a CNS contribution to the pathogenesis and maintenance of neuropathic pain syndromes.

AB - OBJECTIVES: Recent studies have confirmed the contribution of the central nervous system (CNS) to the pathogenesis of Complex Regional Pain Syndrome (CRPS), because animal models of neuropathic pain syndromes demonstrate an overexpression of N-methyl-D-aspartate-receptors in the CNS. The aim of this work was to study the influence of a central acting drug-the N-methyl-D-aspartate receptor antagonist Memantine-in patients with CRPS of one upper extremity. Here we present the results of 6 patients treated with Memantine for 8 weeks. METHODS: All patients developed CRPS after traumatic injury to one upper extremity. To document changes during the study, levels of pain were measured after clenching the hand using a numeric pain intensity scale ranging from 0 (no pain) to 10 (maximum pain). Motor symptoms were documented for the fingers (fingertips to palm and fingernails to table) and the wrist (flexion/extension). Furthermore, the force was analyzed using a JAMAR-Dynamometer and a Pinchmeter. For assessment of central changes, functional magnetic resonance imaging and magnetoencephalography were used to further document the results of other experiments in 1 patient. Autonomic changes were photographed and pictures were compared before and after treatment with Memantine. RESULTS: Six months after treatment with Memantine, all patients showed a significant decrease in their levels of pain which coincided with an improvement in motor symptoms and autonomic changes. The functional magnetic resonance imaging and magnetoencephalography results provided evidence of cortical reorganization [changes in somatotopic maps in the primary somatosensory cortex (S1)]. These changes returned to a cortical pattern comparable to the unaffected side after treatment with Memantine. DISCUSSION: Based on these first results, the use of Memantine for treatment of CRPS seems promising and supports the hypothesis of a CNS contribution to the pathogenesis and maintenance of neuropathic pain syndromes.

KW - Cortical reorganization

KW - CRPS

KW - Memantine

KW - Neuropathic pain

KW - NMDA-receptor

UR - http://www.scopus.com/inward/record.url?scp=33847219596&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847219596&partnerID=8YFLogxK

U2 - 10.1097/AJP.0b013e31802f67a7

DO - 10.1097/AJP.0b013e31802f67a7

M3 - Article

VL - 23

SP - 237

EP - 243

JO - Clinical Journal of Pain

JF - Clinical Journal of Pain

SN - 0749-8047

IS - 3

ER -